Aaron Fletcher, Founder & General Partner at Bios Partners, Fort Worth, Texas, United States — verified investor profile. See sector focus and contact routes.
Aaron G.L. Fletcher, PhD, is the Managing Director and co-founder of Bios Partners, a Fort Worth, Texas-based life sciences venture firm established in 2014. He leads the firm’s investment thesis targeting early-stage seed and later-stage growth companies primarily within the biotech and medical device sectors across underserved regions of the United States, with a focus on the Central US. Typical check sizes range from $50,000 to $5 million for seed and Series A/B rounds, and Fletcher has served as the lead partner on at least six deals. Notable portfolio companies include Opus Genetics, which received a $19 million seed investment from Bios Partners in 2021, as well as Abilitech Medical and TFF Pharmaceuticals, where Fletcher holds board positions. A distinctive point of view in his approach is disrupting geographic favoritism in venture capital by supporting scientific ventures outside traditional hubs like Silicon Valley and the Northeast. His background includes a PhD in biochemistry, over 10 years as an independent consultant in biotech equity, and founding Bios Research to provide healthcare-focused public equity research.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Fort Worth.
Investors like Aaron Fletcher · Full investor directory · Investor access · Company funding database